Literature DB >> 3181269

Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment.

J Gioanni1, J L Fischel, J C Lambert, F Demard, C Mazeau, E Zanghellini, F Ettore, P Formento, P Chauvel, C M Lalanne.   

Abstract

Two new permanent cell lines derived from squamous cell carcinomas of the tongue, CAL 27 and CAL 33, have been established in culture. Both cell lines were isolated in standard culture media without epidermal growth factor or fibroblast feeder layer to avoid obtaining clones of more differentiated cells. Analysis of the morphology, ultrastructure, karyotype and immunohistochemical properties of these two cell lines demonstrated that they are both well characterized, uncontaminated by HeLa cells, and do in fact correspond to transformed epithelial cells that have conserved certain characteristics of the original Malpighian epithelium. CAL 27 and CAL 33 have relatively long doubling times (35 and 43 h respectively). Their response to 14 drugs used for cancer chemotherapy was evaluated by a short term assay based on tritiated thymidine incorporation after exposure to the drugs. CAL 27 was more resistant than CAL 33 in all cases but one. Although cytogenetic examination revealed both lines to be malignant, neither CAL 27 nor CAL 33 produced colonies in soft agar; both lines were tumorigenic after inoculation into nude mice. This study clearly demonstrates the diversity of cancers of a given histologic form, in agreement with the diversity noted previously in vivo. Isolated without the use of any selection criteria, these cell lines constitute appropriate models for the study of human tumors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3181269     DOI: 10.1016/0277-5379(88)90335-5

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  79 in total

1.  A metric and workflow for quality control in the analysis of heterogeneity in phenotypic profiles and screens.

Authors:  Albert Gough; Tong Ying Shun; D Lansing Taylor; Mark Schurdak
Journal:  Methods       Date:  2015-11-04       Impact factor: 3.608

2.  HCS campaign to identify selective inhibitors of IL-6-induced STAT3 pathway activation in head and neck cancer cell lines.

Authors:  Paul A Johnston; Malabika Sen; Yun Hua; Daniel P Camarco; Tong Ying Shun; John S Lazo; Gabriela Mustata Wilson; Lynn O Resnick; Matthew G LaPorte; Peter Wipf; Donna M Huryn; Jennifer R Grandis
Journal:  Assay Drug Dev Technol       Date:  2015-09       Impact factor: 1.738

3.  Establishment and characterization of a squamous cell carcinoma cell line, designated hZK-1, derived from a metastatic lymph node tumor of the tongue.

Authors:  Tetsuya Hirabayashi; Haruka Takahashi; Miho Watanabe; Toshiaki Tachibana
Journal:  Hum Cell       Date:  2017-03-04       Impact factor: 4.174

4.  Combined inhibition of c-Src and epidermal growth factor receptor abrogates growth and invasion of head and neck squamous cell carcinoma.

Authors:  Priya Koppikar; Seung-Ho Choi; Ann Marie Egloff; Quan Cai; Shinsuke Suzuki; Maria Freilino; Hiroshi Nozawa; Sufi M Thomas; William E Gooding; Jill M Siegfried; Jennifer R Grandis
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

5.  Targeting TORC1/2 enhances sensitivity to EGFR inhibitors in head and neck cancer preclinical models.

Authors:  Andre Cassell; Maria L Freilino; Jessica Lee; Sharon Barr; Lin Wang; Mary C Panahandeh; Sufi M Thomas; Jennifer R Grandis
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

6.  Integrative molecular characterization of head and neck cancer cell model genomes.

Authors:  Ivy F L Tsui; Cathie Garnis
Journal:  Head Neck       Date:  2010-09       Impact factor: 3.147

7.  Cyclin D1 overexpression enhances chemosensitivity to TPF chemotherapeutic agents via the caspase-3 pathway in oral cancer.

Authors:  Yong-Jie Hu; Wen-Wen Sun; Tong-Chao Zhao; Ying Liu; Dong-Wang Zhu; Li-Zhen Wang; Jiang Li; Chen-Ping Zhang; Zhi-Yuan Zhang; Lai-Ping Zhong
Journal:  Oncol Lett       Date:  2020-08-24       Impact factor: 2.967

8.  Detection of differentially expressed basal cell proteins by mass spectrometry.

Authors:  Viktor Todorović; Bhushan V Desai; Richard A Eigenheer; Taofei Yin; Evangeline V Amargo; Milan Mrksich; Kathleen J Green; Melanie J Schroeder Patterson
Journal:  Mol Cell Proteomics       Date:  2009-11-30       Impact factor: 5.911

9.  Inhibition of dihydropyrimidine dehydrogenase by alpha-interferon: experimental data on human tumor cell lines.

Authors:  G Milano; J L Fischel; M C Etienne; N Renée; P Formento; A Thyss; M H Gaspard; L Thill; D Cupissol
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 10.  Essentials of oral cancer.

Authors:  César Rivera
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.